PORTUGAL FACILITY

Dinastia is constructing a Phase 1, 2,000 sq/m (21,500 sq/ft) EU-GMP state-of-the-art facility in Sao Pedro do Sul, Portugal. A pre-license was obtained from Portugal’s National Medicines Authority (Infarmed) in December, 2021. The Company intends to build out the facility in stages, as market trends are identified and jurisdictional regulations evolve.